文献速递生殖医学

47,XXY 克氏综合征患者延迟睾丸精子提取不影响取精率,且睾丸精子提取阳性时抗苗勒管激素水平更高

Delaying testicular sperm extraction in 47,XXY Klinefelter patients does not impair the sperm retrieval rate, and AMH levels are higher when TESE is positive.
PubMed 文献 · Hum Reprod · 2022-01-01

该前瞻性平行队列研究纳入法国里昂大学医院157例非嵌合型47,XXY克氏综合征患者,最终分析119例(年轻组61例,15-22岁;成年组58例,23-43岁)。两组睾丸精子提取率无显著差异(年轻组49.2% vs 成年组41.4%,P=0.393),总体取精率45.4%。抗苗勒管激素处于上四分位者取精率显著高于下四分位或低于定量下限者。

要点

  • 年轻组与成年组睾丸精子提取率无显著差异(49.2% vs 41.4%,P=0.393)。
  • 抗苗勒管激素上四分位者取精率67.7%,显著高于下四分位或低于定量下限者的28.9%(P=0.001)。
  • 抗苗勒管激素与抑制素B在年轻组及睾丸精子提取阳性者中均显著更高。

核心结论

  • 年龄并非非嵌合型克氏综合征患者睾丸精子提取的不良预后因素,延迟至成年期手术未损害取精率。
  • 抗苗勒管激素对上四分位者取精率有较好预测价值,优于抑制素B。

研究设计与样本

  • 前瞻性平行纳入两个队列:年轻组15-22岁,成年组23-43岁。
  • 2010年至2020年在法国里昂大学医院生殖医学科纳入157例非嵌合型47,XXY克氏综合征患者,最终分析119例(年轻组61例,成年组58例)。
  • 31例在睾丸精子提取前退出,4例为隐匿精子症,3例无有效激素评估,均被排除。
  • 所有分析患者均在常规睾丸精子提取术前完成临床、激素及精液评估。

主要发现

  • 总体取精率为45.4%。
  • 年轻组取精率49.2% vs 成年组41.4%,差异无统计学意义(P=0.393)。
  • 抗苗勒管激素和抑制素B在年轻组显著更高(抗苗勒管激素P=0.001,抑制素B P<0.001)。
  • 抗苗勒管激素和抑制素B在睾丸精子提取阳性者中显著高于阴性者(抗苗勒管激素P=0.001,抑制素B P=0.036)。
  • 抗苗勒管激素血浆水平上四分位者取精率显著高于下四分位或低于定量下限者:全人群67.7% vs 28.9%(P=0.001),年轻组60% vs 20%(P=0.025),成年组71.4% vs 33.3%(P=0.018)。

关键数值与推荐

  • 年龄分组:年轻组15-22岁,成年组23-43岁。
  • 取精率比较:年轻组49.2% vs 成年组41.4%(P=0.393)。
  • 抗苗勒管激素上四分位 vs 下四分位或低于定量下限的取精率:全人群67.7% vs 28.9%(P=0.001)。
  • 年轻组抗苗勒管激素上四分位 vs 下四分位或低于定量下限的取精率:60% vs 20%(P=0.025)。
  • 成年组抗苗勒管激素上四分位 vs 下四分位或低于定量下限的取精率:71.4% vs 33.3%(P=0.018)。

临床怎么用

  • 作者认为年龄在15-22岁与23-44岁患者比较中不表现为不良因素,与部分研究结论相反。
  • 作者认为未来抑制素B和抗苗勒管激素检测准确性的提高可能有助于区分存在持续生精灶的患者并指导临床决策与患者告知。

局限性

  • 全研究均行常规睾丸精子提取术,不能排除若行显微取精术会得到不同结果的可能性。
  • 由于抑制素B和抗苗勒管激素检测灵敏度有限,大量患者数值低于定量下限,无法定义可预测睾丸精子提取阴性的阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Should testicular sperm extraction (TESE) in non-mosaic 47,XXY Klinefelter syndrome (KS) patients be performed soon after puberty or could it be delayed until adulthood? SUMMARY ANSWER: The difference in sperm retrieval rate (SRR) in TESE was not significant between the 'Young' (15-22 years old) cohort and the 'Adult' (23-43 years old) cohort of non-mosaic KS patients recruited prospectively in parallel. WHAT IS KNOWN ALREADY: Several studies have tried to define predictive factors for TESE outcome in non-mosaic KS patients, with very heterogeneous results. Some authors have found that age was a pejorative factor and recommended performing TESE soon after puberty. To date, no predictive factors have been unanimously recognized to guide clinicians in deciding to perform TESE in azoospermic KS patients. STUDY DESIGN, SIZE, DURATION: Two cohorts (Young: 15-22 years old; Adult: 23-43 years old) were included prospectively in parallel. A total of 157 non-mosaic 47,XXY KS patients were included between 2010 and 2020 in the reproductive medicine department of the University Hospital of Lyon, France. However 31 patients gave up before TESE, four had cryptozoospermia and three did not have a valid hormone assessment; these were excluded from this study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data for 119 patients (61 Young and 58 Adult) were analyzed. All of these patients had clinical, hormonal and seminal evaluation before conventional TESE (c-TESE). MAIN RESULTS AND THE ROLE OF CHANCE: The global SRR was 45.4%. SRRs were not significantly different between the two age groups: Young SRR=49.2%, Adult SRR = 41.4%; P = 0.393. Anti-Müllerian hormone (AMH) and inhibin B were significantly higher in the Young group (AMH: P = 0.001, Inhibin B: P < 0.001), and also higher in patients with a positive TESE than in those with a negative TESE (AMH: P = 0.001, Inhibin B: P = 0.036). The other factors did not differ between age groups or according to TESE outcome. AMH had a better predictive value than inhibin B. SRRs were significantly higher in the upper quartile of AMH plasma levels than in the lower quartile (or in cases with AMH plasma level below the quantification limit): 67.7% versus 28.9% in the whole population (P = 0.001), 60% versus 20% in the Young group (P = 0.025) and 71.4% versus 33.3% in the Adult group (P = 0.018). LIMITATIONS, REASONS FOR CAUTION: c-TESE was performed in the whole study; we cannot rule out the possibility of different results if microsurgical TESE had been performed. Because of the limited sensitivity of inhibin B and AMH assays, a large number of patients had values lower than the quantification limits, preventing the definition a threshold below which negative TESE can be predicted. WIDER IMPLICATIONS OF THE FINDINGS: In contrast to some studies, age did not appear as a pejorative factor when comparing patients 15-22 and 23-44 years of age. Improved accuracy of inhibin B and AMH assays in the future might still allow discrimination of patients with persistent foci of spermatogenesis and guide clinician decision-making and patient information. STUDY FUNDING/COMPETING INTEREST(S): The study was supported by a grant from the French Ministry of Health D50621 (Programme Hospitalier de Recherche Clinical Régional 2008). The authors have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: NCT01918280.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Renault L, Labrune E, Giscard d'Estaing S, et al. Delaying testicular sperm extraction in 47,XXY Klinefelter patients does not impair the sperm retrieval rate, and AMH levels are higher when TESE is positive. Hum Reprod. 2022. PMID: 36112034. doi:10.1093/humrep/deac203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。